Understand the Strategies and developments in Pharmaceutical Parallel Trade

This year’s Parallel Trade conference promises to present attendees with an in-depth overview and provide the prefect forum for debate and discussion
By: SMi Group
 
Feb. 2, 2012 - PRLog -- This is the final week to register for SMi’s 6th annual Pharmaceutical Parallel Trade Conference, taking place on 6th & 7th February 2012 at the Copthorne Tara Hotel in London. This year's event will bring together expert speakers from different sectors within the industry, each with differing opinions and perspectives to offer. In such a rapidly developing field of parallel trade, it is essential that companies are kept up to date with the latest developments, regulations and strategies.

With the growth of parallel trade of pharmaceuticals in the European Union increasing consistently (despite numerous challenges from some of the industry’s biggest players) this event is more relevant than ever. The principles of free movement of goods and the regional exhaustion of intellectual property rights, as well as the European Court of Justice consistently ruling in their favour on cases relating to trademark issues have led to great financial success for parallel traders. In response, pharmaceutical companies are now looking towards new solutions and strategies to address parallel trade, leading case studies of which will be discussed and presented at the 2012 conference.

Why should you attend this event?
•   Hear about new techniques, strategies and developments in the field of parallel trade
•   Understand the European directives and regulations
•   Discuss risks that counterfeiting and repackaging in parallel trade may pose to patient safety
•   Learn from multiple case studies demonstrating real life data and processes that work
•   Develop strategies and techniques to limit the concerns and issues associated with parallel trade
•   Network with key industry associates and solution providers to share valuable experiences

Key Speakers Include:

•   Janice Haigh, Senior Director, Pricing & Market Access Europe, Astellas

•   Eric Noehrenberg, Director, Public Affairs for Market Access, Shire Pharmaceuticals

•   Nosh Lentin, Vice President of IT, UCB

•   Gabriele Ghirlanda, Pricing & Reimbursement Manager, Boehringer Ingelheim

•   Jim Thomson, Chairman, EAASM

•   Heinz Kobelt, Secretary General, EAEPC

•   Dermot Glynn, Chairman, Europe Economics

Visit our website here: www.smi-online.co.uk/2012paralleltrade33.asp

Alternatively or contact Ninica Hussain on: +44 (0) 20 7827 6115
e-mail: nhussain@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Pharma, Counterfeiting, Regulations
Industry:Pharmaceuticals
Location:England
Subject:Services
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share